🔍 Rechercher dans les archives
MYO technology enables DNA delivery of incretin agonists for durable weight loss
Researchers from Renbio Inc. and Louisiana State University investigated the delivery of plasmid DNA encoding new glucagon-like peptide-1(GLP-1)-based...
Elaaj Bio advances gene therapy for CDKL5 deficiency disorder
Elaaj Bio, a wholly owned subsidiary of the nonprofit Loulou Foundation, has entered into a partnership with Viralgen Vector Core SL to advance a gene...
Eyes are first prize for newco Link Biologics
The classic origin story for a biotech startup is that of a scientist who nurtures his work out of a university and to commercial success. For Link Bi...
Funding at Signadori Bio to advance monocyte immunotherapies
Signadori Bio SAS has successfully completed its seed extension financing round, bringing to €11.1 million (US$13 million) the total raised to suppo...
Alzecure’s TrkA modulator combines pain relief with joint protection
Researchers from Alzecure Pharma AB and collaborators reported preclinical efficacy data on ACD-137, a selective negative allosteric TrkA modulator in...
Kymera’s IRF5 degrader shows potential in IBD treatment
IRF5 is an autoimmune-associated transcription factor genetically linked to inflammatory bowel disease (IBD) and other autoimmune disorders. At the re...
Apertura Gene Therapy and TSC Alliance partner on gene therapies
Apertura Gene Therapy LLC and the TSC Alliance have established a collaboration to advance gene therapy programs designed to treat tuberous sclerosis ...
Simcere Zaiming’s SIM-0613 cleared to enter clinic in China
Simcere Zaiming Pharmaceutical Co. Ltd.’s SIM-0613 for injection has received clinical trial approval from China’s National Medical Products Admin...
New SMARCA2 degrader for SMARCA4-deficient cancers described
SMARCA4-deficient cells have shown dependency on SMARCA2 for survival, suggesting SMARCA2 as a promising synthetic lethal target in SMARCA4-deficient ...
Oxford professor Shimon Whiteson leaves Waymo to lead multi-agent learning at DeepMind
The reinforcement learning researcher, whose work on multi-agent systems has been cited thousands of times, will build a new team at DeepMind after si...
New at-home test could ‘revolutionise’ Alzheimer’s diagnosis
...
25 years of chemistry that simply clicks
Nature, Published online: 06 May 2026; doi:10.1038/d41586-026-01155-x When the concept of ‘click’ chemistry — highly effective and specific reac...
Scientists unveil Alzheimer’s finger prick test to predict risk of disease
Researchers found the blood test can be used with computerised cognitive testing to identify a person’s risk of Alzheimer’s...
Global inkjet market to reach 177bn USD
The global inkjet market is forecast to reach 177.3 billion USD by 2031, according to new research from Smithers, with the graphic and packaging segme...
A skull full of surprises: Discovering the evolutionary secrets of fish brains
A new study in Proceedings of the Royal Society B reveals the surprising neurological landscape of fish brains. Harvard researchers map the internal s...
Climate scientist finds large errors in a global climate pollution database
New research from Northern Arizona University found that a global greenhouse gas emissions database produced by the Climate TRACE consortium, co-found...
Viridian’s Reveal-2 beats expectations with elegrobart in TED
Top-line data from the Reveal-2 phase III trial of elegrobart to treat chronic thyroid eye disease (TED) drove Viridian Therapeutics Inc.’s stock up...
Cytokinetics metrics satisfy in nHCM phase III
Thanks to a trial design that, according to Evercore ISI analyst Cory Kasimov, “played out exactly as drawn up,” Cytokinetics Inc. hit both of the...
White House looks to expand MFN pricing for $530B-plus in savings
Amid calls for transparency on the most-favored nation (MFN) pricing deals U.S. President Donald Trump has reached with 17 biopharma companies, the Wh...
MMI’s Symani system treats Alzheimer’s patient in IDE study
Medical Microinstruments Inc.’s (MMI) Symani surgical system was used to treat a patient with Alzheimer’s disease as part of a study evaluating ro...